The global Bio-based Hemostatic Powder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bio-based Hemostatic Powder competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Bio-based hemostatic powder is a hemostatic product made from natural biomaterials, designed to quickly control bleeding and promote wound healing. It is usually made of biomaterials such as plant extracts, chitosan, collagen, etc., and has good biocompatibility and degradability. Its working mechanism is to quickly stop bleeding by adsorbing blood, promoting platelet aggregation and accelerating blood clot formation. Bio-based hemostatic powder is widely used in trauma emergency treatment, surgery and other medical scenarios because its natural ingredients are friendly to the human body and can effectively reduce the risk of infection and complications.

The North American market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Bio-based Hemostatic Powder is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Bio-based Hemostatic Powder include Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, Hemostasis, MedTrade Products, Lanhine Medical, Haiyuan Hairun, Yancheng Yankang Medical Equipment, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Bio-based Hemostatic Powder market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bio-based Hemostatic Powder. The Bio-based Hemostatic Powder market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Bio-based Hemostatic Powder market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Bio-based Hemostatic Powder manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Bio-based Hemostatic Powder Market Report

Report Metric	Details
Report Name	Bio-based Hemostatic Powder Market
Segment by Type	Oxidized Cellulose Polysaccharides Other
by Application	Surgery First Aid
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, Hemostasis, MedTrade Products, Lanhine Medical, Haiyuan Hairun, Yancheng Yankang Medical Equipment, Success Bio-Tech, Beijing Aitekang Medical Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Bio-based Hemostatic Powder manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Bio-based Hemostatic Powder sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Bio-based Hemostatic Powder Market report?

Ans: The main players in the Bio-based Hemostatic Powder Market are Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, Hemostasis, MedTrade Products, Lanhine Medical, Haiyuan Hairun, Yancheng Yankang Medical Equipment, Success Bio-Tech, Beijing Aitekang Medical Technology

What are the Application segmentation covered in the Bio-based Hemostatic Powder Market report?

Ans: The Applications covered in the Bio-based Hemostatic Powder Market report are Surgery, First Aid

What are the Type segmentation covered in the Bio-based Hemostatic Powder Market report?

Ans: The Types covered in the Bio-based Hemostatic Powder Market report are Oxidized Cellulose, Polysaccharides, Other

1 Bio-based Hemostatic Powder Market Overview

1.1 Product Definition

1.2 Bio-based Hemostatic Powder by Type

1.2.1 Global Bio-based Hemostatic Powder Market Value by Type: 2025 vs 2032

1.2.2 Oxidized Cellulose

1.2.3 Polysaccharides

1.2.4 Other

1.3 Bio-based Hemostatic Powder by Application

1.3.1 Global Bio-based Hemostatic Powder Market Value by Application: 2025 vs 2032

1.3.2 Surgery

1.3.3 First Aid

1.4 Global Bio-based Hemostatic Powder Market Size Estimates and Forecasts

1.4.1 Global Bio-based Hemostatic Powder Revenue 2021–2032

1.4.2 Global Bio-based Hemostatic Powder Sales 2021–2032

1.4.3 Global Bio-based Hemostatic Powder Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Bio-based Hemostatic Powder Market Competition by Manufacturers

2.1 Global Bio-based Hemostatic Powder Sales Market Share by Manufacturers (2021–2026)

2.2 Global Bio-based Hemostatic Powder Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Bio-based Hemostatic Powder Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Bio-based Hemostatic Powder, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Bio-based Hemostatic Powder, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Bio-based Hemostatic Powder, Product Types and Applications

2.7 Global Key Manufacturers of Bio-based Hemostatic Powder, Date of Entry into the Industry

2.8 Global Bio-based Hemostatic Powder Market Competitive Situation and Trends

2.8.1 Global Bio-based Hemostatic Powder Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Bio-based Hemostatic Powder Players Market Share by Revenue

2.8.3 Global Bio-based Hemostatic Powder Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bio-based Hemostatic Powder Market Scenario by Region

3.1 Global Bio-based Hemostatic Powder Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Bio-based Hemostatic Powder Sales by Region: 2021–2032

3.2.1 Global Bio-based Hemostatic Powder Sales by Region: 2021–2026

3.2.2 Global Bio-based Hemostatic Powder Sales by Region: 2027–2032

3.3 Global Bio-based Hemostatic Powder Revenue by Region: 2021–2032

3.3.1 Global Bio-based Hemostatic Powder Revenue by Region: 2021–2026

3.3.2 Global Bio-based Hemostatic Powder Revenue by Region: 2027–2032

3.4 North America Bio-based Hemostatic Powder Market Facts & Figures by Country

3.4.1 North America Bio-based Hemostatic Powder Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Bio-based Hemostatic Powder Sales by Country (2021–2032)

3.4.3 North America Bio-based Hemostatic Powder Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Bio-based Hemostatic Powder Market Facts & Figures by Country

3.5.1 Europe Bio-based Hemostatic Powder Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Bio-based Hemostatic Powder Sales by Country (2021–2032)

3.5.3 Europe Bio-based Hemostatic Powder Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bio-based Hemostatic Powder Market Facts & Figures by Region

3.6.1 Asia Pacific Bio-based Hemostatic Powder Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Bio-based Hemostatic Powder Sales by Region (2021–2032)

3.6.3 Asia Pacific Bio-based Hemostatic Powder Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Bio-based Hemostatic Powder Market Facts & Figures by Country

3.7.1 Latin America Bio-based Hemostatic Powder Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Bio-based Hemostatic Powder Sales by Country (2021–2032)

3.7.3 Latin America Bio-based Hemostatic Powder Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Bio-based Hemostatic Powder Market Facts & Figures by Country

3.8.1 Middle East and Africa Bio-based Hemostatic Powder Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Bio-based Hemostatic Powder Sales by Country (2021–2032)

3.8.3 Middle East and Africa Bio-based Hemostatic Powder Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bio-based Hemostatic Powder Sales by Type (2021–2032)

4.1.1 Global Bio-based Hemostatic Powder Sales by Type (2021–2026)

4.1.2 Global Bio-based Hemostatic Powder Sales by Type (2027–2032)

4.1.3 Global Bio-based Hemostatic Powder Sales Market Share by Type (2021–2032)

4.2 Global Bio-based Hemostatic Powder Revenue by Type (2021–2032)

4.2.1 Global Bio-based Hemostatic Powder Revenue by Type (2021–2026)

4.2.2 Global Bio-based Hemostatic Powder Revenue by Type (2027–2032)

4.2.3 Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021–2032)

4.3 Global Bio-based Hemostatic Powder Price by Type (2021–2032)

5 Segment by Application

5.1 Global Bio-based Hemostatic Powder Sales by Application (2021–2032)

5.1.1 Global Bio-based Hemostatic Powder Sales by Application (2021–2026)

5.1.2 Global Bio-based Hemostatic Powder Sales by Application (2027–2032)

5.1.3 Global Bio-based Hemostatic Powder Sales Market Share by Application (2021–2032)

5.2 Global Bio-based Hemostatic Powder Revenue by Application (2021–2032)

5.2.1 Global Bio-based Hemostatic Powder Revenue by Application (2021–2026)

5.2.2 Global Bio-based Hemostatic Powder Revenue by Application (2027–2032)

5.2.3 Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021–2032)

5.3 Global Bio-based Hemostatic Powder Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Johnson & Johnson

6.1.1 Johnson & Johnson Company Information

6.1.2 Johnson & Johnson Description and Business Overview

6.1.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio

6.1.5 Johnson & Johnson Recent Developments/Updates

6.2 Medtronic

6.2.1 Medtronic Company Information

6.2.2 Medtronic Description and Business Overview

6.2.3 Medtronic Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Medtronic Bio-based Hemostatic Powder Product Portfolio

6.2.5 Medtronic Recent Developments/Updates

6.3 Baxter

6.3.1 Baxter Company Information

6.3.2 Baxter Description and Business Overview

6.3.3 Baxter Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Baxter Bio-based Hemostatic Powder Product Portfolio

6.3.5 Baxter Recent Developments/Updates

6.4 BioCer Entwicklungs-GmbH

6.4.1 BioCer Entwicklungs-GmbH Company Information

6.4.2 BioCer Entwicklungs-GmbH Description and Business Overview

6.4.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio

6.4.5 BioCer Entwicklungs-GmbH Recent Developments/Updates

6.5 BD

6.5.1 BD Company Information

6.5.2 BD Description and Business Overview

6.5.3 BD Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 BD Bio-based Hemostatic Powder Product Portfolio

6.5.5 BD Recent Developments/Updates

6.6 Hemostasis

6.6.1 Hemostasis Company Information

6.6.2 Hemostasis Description and Business Overview

6.6.3 Hemostasis Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Hemostasis Bio-based Hemostatic Powder Product Portfolio

6.6.5 Hemostasis Recent Developments/Updates

6.7 MedTrade Products

6.7.1 MedTrade Products Company Information

6.7.2 MedTrade Products Description and Business Overview

6.7.3 MedTrade Products Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 MedTrade Products Bio-based Hemostatic Powder Product Portfolio

6.7.5 MedTrade Products Recent Developments/Updates

6.8 Lanhine Medical

6.8.1 Lanhine Medical Company Information

6.8.2 Lanhine Medical Description and Business Overview

6.8.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Lanhine Medical Bio-based Hemostatic Powder Product Portfolio

6.8.5 Lanhine Medical Recent Developments/Updates

6.9 Haiyuan Hairun

6.9.1 Haiyuan Hairun Company Information

6.9.2 Haiyuan Hairun Description and Business Overview

6.9.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio

6.9.5 Haiyuan Hairun Recent Developments/Updates

6.10 Yancheng Yankang Medical Equipment

6.10.1 Yancheng Yankang Medical Equipment Company Information

6.10.2 Yancheng Yankang Medical Equipment Description and Business Overview

6.10.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio

6.10.5 Yancheng Yankang Medical Equipment Recent Developments/Updates

6.11 Success Bio-Tech

6.11.1 Success Bio-Tech Company Information

6.11.2 Success Bio-Tech Description and Business Overview

6.11.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio

6.11.5 Success Bio-Tech Recent Developments/Updates

6.12 Beijing Aitekang Medical Technology

6.12.1 Beijing Aitekang Medical Technology Company Information

6.12.2 Beijing Aitekang Medical Technology Description and Business Overview

6.12.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio

6.12.5 Beijing Aitekang Medical Technology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bio-based Hemostatic Powder Industry Chain Analysis

7.2 Bio-based Hemostatic Powder Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bio-based Hemostatic Powder Production Mode & Process Analysis

7.4 Bio-based Hemostatic Powder Sales and Marketing

7.4.1 Bio-based Hemostatic Powder Sales Channels

7.4.2 Bio-based Hemostatic Powder Distributors

7.5 Bio-based Hemostatic Powder Customer Analysis

8 Bio-based Hemostatic Powder Market Dynamics

8.1 Bio-based Hemostatic Powder Industry Trends

8.2 Bio-based Hemostatic Powder Market Drivers

8.3 Bio-based Hemostatic Powder Market Challenges

8.4 Bio-based Hemostatic Powder Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Medtronic Inc

Baxter

BioCer Entwicklungs-GmbH.

Yancheng Yankang Medical Equipment

Success Bio-Tech

Beijing Aitekang Medical Technology

List of Tables

Table 1. Global Bio-based Hemostatic Powder Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Bio-based Hemostatic Powder Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Bio-based Hemostatic Powder Market Competitive Situation by Manufacturers in 2025

Table 4. Global Bio-based Hemostatic Powder Sales (Units) of Key Manufacturers (2021–2026)

Table 5. Global Bio-based Hemostatic Powder Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Bio-based Hemostatic Powder Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Bio-based Hemostatic Powder Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Bio-based Hemostatic Powder Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Bio-based Hemostatic Powder, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Bio-based Hemostatic Powder, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Bio-based Hemostatic Powder, Product Types and Applications

Table 12. Global Key Manufacturers of Bio-based Hemostatic Powder, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bio-based Hemostatic Powder Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bio-based Hemostatic Powder Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bio-based Hemostatic Powder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Bio-based Hemostatic Powder Sales by Region (Units), 2021–2026

Table 18. Global Bio-based Hemostatic Powder Sales Market Share by Region (2021–2026)

Table 19. Global Bio-based Hemostatic Powder Sales by Region (Units), 2027–2032

Table 20. Global Bio-based Hemostatic Powder Sales Market Share by Region (2027–2032)

Table 21. Global Bio-based Hemostatic Powder Revenue by Region (US$ Million), 2021–2026

Table 22. Global Bio-based Hemostatic Powder Revenue Market Share by Region (2021–2026)

Table 23. Global Bio-based Hemostatic Powder Revenue by Region (US$ Million), 2027–2032

Table 24. Global Bio-based Hemostatic Powder Revenue Market Share by Region (2027–2032)

Table 25. North America Bio-based Hemostatic Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Bio-based Hemostatic Powder Sales by Country (Units), 2021–2026

Table 27. North America Bio-based Hemostatic Powder Sales by Country (Units), 2027–2032

Table 28. North America Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2021–2026

Table 29. North America Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Bio-based Hemostatic Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Bio-based Hemostatic Powder Sales by Country (Units), 2021–2026

Table 32. Europe Bio-based Hemostatic Powder Sales by Country (Units), 2027–2032

Table 33. Europe Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Bio-based Hemostatic Powder Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Bio-based Hemostatic Powder Sales by Region (Units), 2021–2026

Table 37. Asia Pacific Bio-based Hemostatic Powder Sales by Region (Units), 2027–2032

Table 38. Asia Pacific Bio-based Hemostatic Powder Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Bio-based Hemostatic Powder Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Bio-based Hemostatic Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Bio-based Hemostatic Powder Sales by Country (Units), 2021–2026

Table 42. Latin America Bio-based Hemostatic Powder Sales by Country (Units), 2027–2032

Table 43. Latin America Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Bio-based Hemostatic Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Bio-based Hemostatic Powder Sales by Country (Units), 2021–2026

Table 47. Middle East and Africa Bio-based Hemostatic Powder Sales by Country (Units), 2027–2032

Table 48. Middle East and Africa Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Bio-based Hemostatic Powder Revenue by Country (US$ Million), 2027–2032

Table 50. Global Bio-based Hemostatic Powder Sales (Units) by Type (2021–2026)

Table 51. Global Bio-based Hemostatic Powder Sales (Units) by Type (2027–2032)

Table 52. Global Bio-based Hemostatic Powder Sales Market Share by Type (2021–2026)

Table 53. Global Bio-based Hemostatic Powder Sales Market Share by Type (2027–2032)

Table 54. Global Bio-based Hemostatic Powder Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Bio-based Hemostatic Powder Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021–2026)

Table 57. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2027–2032)

Table 58. Global Bio-based Hemostatic Powder Price (US$/Unit) by Type (2021–2026)

Table 59. Global Bio-based Hemostatic Powder Price (US$/Unit) by Type (2027–2032)

Table 60. Global Bio-based Hemostatic Powder Sales (Units) by Application (2021–2026)

Table 61. Global Bio-based Hemostatic Powder Sales (Units) by Application (2027–2032)

Table 62. Global Bio-based Hemostatic Powder Sales Market Share by Application (2021–2026)

Table 63. Global Bio-based Hemostatic Powder Sales Market Share by Application (2027–2032)

Table 64. Global Bio-based Hemostatic Powder Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Bio-based Hemostatic Powder Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021–2026)

Table 67. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2027–2032)

Table 68. Global Bio-based Hemostatic Powder Price (US$/Unit) by Application (2021–2026)

Table 69. Global Bio-based Hemostatic Powder Price (US$/Unit) by Application (2027–2032)

Table 70. Johnson & Johnson Company Information

Table 71. Johnson & Johnson Description and Business Overview

Table 72. Johnson & Johnson Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Johnson & Johnson Bio-based Hemostatic Powder Product

Table 74. Johnson & Johnson Recent Developments/Updates

Table 75. Medtronic Company Information

Table 76. Medtronic Description and Business Overview

Table 77. Medtronic Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Medtronic Bio-based Hemostatic Powder Product

Table 79. Medtronic Recent Developments/Updates

Table 80. Baxter Company Information

Table 81. Baxter Description and Business Overview

Table 82. Baxter Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Baxter Bio-based Hemostatic Powder Product

Table 84. Baxter Recent Developments/Updates

Table 85. BioCer Entwicklungs-GmbH Company Information

Table 86. BioCer Entwicklungs-GmbH Description and Business Overview

Table 87. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product

Table 89. BioCer Entwicklungs-GmbH Recent Developments/Updates

Table 90. BD Company Information

Table 91. BD Description and Business Overview

Table 92. BD Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. BD Bio-based Hemostatic Powder Product

Table 94. BD Recent Developments/Updates

Table 95. Hemostasis Company Information

Table 96. Hemostasis Description and Business Overview

Table 97. Hemostasis Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Hemostasis Bio-based Hemostatic Powder Product

Table 99. Hemostasis Recent Developments/Updates

Table 100. MedTrade Products Company Information

Table 101. MedTrade Products Description and Business Overview

Table 102. MedTrade Products Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. MedTrade Products Bio-based Hemostatic Powder Product

Table 104. MedTrade Products Recent Developments/Updates

Table 105. Lanhine Medical Company Information

Table 106. Lanhine Medical Description and Business Overview

Table 107. Lanhine Medical Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Lanhine Medical Bio-based Hemostatic Powder Product

Table 109. Lanhine Medical Recent Developments/Updates

Table 110. Haiyuan Hairun Company Information

Table 111. Haiyuan Hairun Description and Business Overview

Table 112. Haiyuan Hairun Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Haiyuan Hairun Bio-based Hemostatic Powder Product

Table 114. Haiyuan Hairun Recent Developments/Updates

Table 115. Yancheng Yankang Medical Equipment Company Information

Table 116. Yancheng Yankang Medical Equipment Description and Business Overview

Table 117. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product

Table 119. Yancheng Yankang Medical Equipment Recent Developments/Updates

Table 120. Success Bio-Tech Company Information

Table 121. Success Bio-Tech Description and Business Overview

Table 122. Success Bio-Tech Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 123. Success Bio-Tech Bio-based Hemostatic Powder Product

Table 124. Success Bio-Tech Recent Developments/Updates

Table 125. Beijing Aitekang Medical Technology Company Information

Table 126. Beijing Aitekang Medical Technology Description and Business Overview

Table 127. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 128. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product

Table 129. Beijing Aitekang Medical Technology Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Bio-based Hemostatic Powder Distributors List

Table 133. Bio-based Hemostatic Powder Customers List

Table 134. Bio-based Hemostatic Powder Market Trends

Table 135. Bio-based Hemostatic Powder Market Drivers

Table 136. Bio-based Hemostatic Powder Market Challenges

Table 137. Bio-based Hemostatic Powder Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bio-based Hemostatic Powder

Figure 2. Global Bio-based Hemostatic Powder Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Bio-based Hemostatic Powder Market Share by Type: 2025 & 2032

Figure 4. Oxidized Cellulose Product Picture

Figure 5. Polysaccharides Product Picture

Figure 6. Other Product Picture

Figure 7. Global Bio-based Hemostatic Powder Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Bio-based Hemostatic Powder Market Share by Application: 2025 & 2032

Figure 9. Surgery

Figure 10. First Aid

Figure 11. Global Bio-based Hemostatic Powder Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Bio-based Hemostatic Powder Market Size (US$ Million), 2021–2032

Figure 13. Global Bio-based Hemostatic Powder Sales (Units), 2021–2032

Figure 14. Global Bio-based Hemostatic Powder Average Price (US$/Unit), 2021–2032

Figure 15. Bio-based Hemostatic Powder Report Years Considered

Figure 16. Bio-based Hemostatic Powder Sales Share by Manufacturers in 2025

Figure 17. Global Bio-based Hemostatic Powder Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Bio-based Hemostatic Powder Players: Market Share by Revenue in Bio-based Hemostatic Powder in 2025

Figure 19. Bio-based Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Bio-based Hemostatic Powder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Bio-based Hemostatic Powder Sales Market Share by Country (2021–2032)

Figure 22. North America Bio-based Hemostatic Powder Revenue Market Share by Country (2021–2032)

Figure 23. United States Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Bio-based Hemostatic Powder Sales Market Share by Country (2021–2032)

Figure 26. Europe Bio-based Hemostatic Powder Revenue Market Share by Country (2021–2032)

Figure 27. Germany Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Bio-based Hemostatic Powder Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Bio-based Hemostatic Powder Revenue Market Share by Region (2021–2032)

Figure 34. China Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. China Taiwan Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Southeast Asia Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Latin America Bio-based Hemostatic Powder Sales Market Share by Country (2021–2032)

Figure 42. Latin America Bio-based Hemostatic Powder Revenue Market Share by Country (2021–2032)

Figure 43. Mexico Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Brazil Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Argentina Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Colombia Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Bio-based Hemostatic Powder Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Bio-based Hemostatic Powder Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Bio-based Hemostatic Powder by Type (2021–2032)

Figure 53. Global Revenue Market Share of Bio-based Hemostatic Powder by Type (2021–2032)

Figure 54. Global Bio-based Hemostatic Powder Price (US$/Unit) by Type (2021–2032)

Figure 55. Global Sales Market Share of Bio-based Hemostatic Powder by Application (2021–2032)

Figure 56. Global Revenue Market Share of Bio-based Hemostatic Powder by Application (2021–2032)

Figure 57. Global Bio-based Hemostatic Powder Price (US$/Unit) by Application (2021–2032)

Figure 58. Bio-based Hemostatic Powder Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions